ITEMS IN AFP WITH KEYWORD:
Family Planning and Contraception
Giving an injection of medroxyprogesterone (Depo-Provera) on any day of a patient's menstrual cycle decreases unintended pregnancies. For other hormonal methods, there is limited evidence. Compared with deferring until the patient's next menses, immediate start of hormonal methods appears to produce...
Aug 1, 2009 Issue
Contraceptive Patch and Vaginal Ring vs. Combined Oral Contraceptives [Cochrane for Clinicians]
Based on moderate quality evidence, contraceptive effectiveness of the vaginal ring or patch is similar to COC. Compliance is better with the patch, but its use is discontinued more often than COCs or the ring because of adverse effects. Vaginal ring and COC users have similar rates of pregnancy, co...
Lybrel appears to be as safe and effective as other combined oral contraceptives; however, at this time, there is little published data about this specific product. Other combined monophasic oral contraceptives, some of which cost less than Lybrel, can be used continuously and have been shown to produce similar results.
Sep 1, 2007 Issue
Advance Provision for Emergency Oral Contraception [Cochrane for Clinicians]
Providing oral emergency contraceptives in advance to fertile women for use after unprotected sexual intercourse (i.e., advance provision) does not affect pregnancy rates, condom use, sexually transmitted infection rates, or type of contraception used. Advance provision more than doubles the odds th...
Guidelines on the use of hormonal contraceptives in women with underlying medical conditions are available from the American College of Obstetricians and Gynecologists (ACOG). In some women, drugs taken for certain chronic conditions may alter the effectiveness of hormonal contraceptives.
Vasectomy remains an important option for contraception. Research findings have clarified many questions regarding patient selection, optimal technique, postsurgical follow-up, and risk of long-term complications. Men who receive vasectomies tend to be non-Hispanic whites, well educated, married or ...
Nov 15, 2006 Issue
Noncontraceptive Uses of the Levonorgestrel Intrauterine System [Practice Guidelines]
Although the levonorgestrel-releasing intrauterine system (Mirena) is approved for contraception, it also may have noncontraceptive uses, such as treating idiopathic menorrhagia. The American College of Obstetricians and Gynecologists (ACOG) published a committee opinion to address the noncontraceptive uses of this system.
Most women can safely begin taking hormonal birth control products immediately after an office visit, at any point in the menstrual cycle. Because hormonal contraceptives do not accelerate cervical neoplasia or interfere with cervical cytology, women who have not had a recent Papanicolaou smear can ...
The levonorgestrel-releasing intrauterine system is a reliable, reversible, low-maintenance method of long-term contraception. Rates of failure are similar to those of female sterilization, and the risk of expulsion is minimal for most users.
Mar 1, 2006 Issue
Cyclic vs. Continuous or Extended- Cycle Combined Contraceptives [Cochrane for Clinicians]
Evidence shows no difference in safety or effectiveness between cyclic and continuous or extended-cycle combined contraceptives. There are fewer menstrual symptoms with extended-cycle contraceptives. Patients’ satisfaction and adherence is similar for all types.